Clinical Trial Update: Prophylactic Treatment of Travellers' Diarrhoea With Rifaximin [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating rifaximin for the prophylaxis of travellers' diarrhea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Travelers Diarrhea

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: Dr. Philipp Zanger, MD MSc DTM | Conditions: Diarrhoea | Phase 3 | Status: COMPLETED